Bioelectrix won Falling Walls Lab Gothenburg
We are proud to share that Bioelectrix has won Falling Walls Lab Gothenburg 2026, hosted by Chalmers University of Technology, with the pitch “Breaking the Wall of Bioelectric Wound Healing.” This recognition is an important milestone for our team and for the journey we are on: developing bioelectric technologies that can support faster and more effective wound […]
Elektroniktidningen (ETN)
We’re excited to share that Elektroniktidningen (ETN) has published an article about Bioelectrix and the bioelectronic technology behind our wound care solution ⚡️ The piece highlights how controlled direct current stimulation can support the healing process in hard-to-heal wounds—and how we’re developing an approach designed for clinical practicality and future scalability. Read it here:ETN ARTICLE
Building the health economics case for Bioelectrix
Bioelectrix is developing a new medical device to actively accelerate wound healing. The technology itself is important, but in wound care, strong technology is not enough. For a solution to be adopted at scale, it must also prove that it reduces the total burden on healthcare systems. That means showing, in a credible and structured […]
Bioelectrix joins CO-AX Accelerator at Sahlgrenska Science Park
Bioelectrix has been selected for the CO-AX Accelerator at Sahlgrenska Science Park, joining a cohort of health innovators shaping the next generation of healthcare solutions. As part of the program, Bioelectrix will accelerate the development of our bioelectronic wound care solution—designed to support treatment of hard-to-heal wounds through biocompatible electrostimulation and real-time monitoring. CO-AX recently introduced the new […]
Bioelectrix appoints Jan Hörling as new Chair of the Board
Bioelectrix is pleased to announce the appointment of Jan Hörling as our new Chair of the Board. Jan joins Bioelectrix at an exciting time as we continue to strengthen our strategy, build momentum, and advance our mission to improve outcomes for patients with hard-to-heal wounds. Jan brings extensive experience from the life science and medtech sectors, with senior leadership […]
Bioelectrix selected for the REACH 2025–26 cohort
Bioelectrix has been selected as one of eight Nordic deep-tech teams in the REACH 2025–26 cohort, a Silicon Valley–based incubator program run by Nordic Innovation House to accelerate the commercialisation of research-driven technologies with global ambition. Why REACH matters for Bioelectrix Building breakthrough medtech starts with strong technology but winning in the market requires much more than […]
Bioelectrix explores the German market for clinical collaboration and growth
🇩🇪 Back from Germany — and energized about what’s ahead for Bioelectrix ⚡️ Bioelectrix recently traveled to Germany as part of a delegation focused on strengthening cross-border collaboration in healthcare innovation. The visit gave us valuable first-hand insight into the German healthcare market, including opportunities for clinical collaboration, market entry pathways, and future investor dialogue. Germany is consistently highlighted as […]
The future of wound care is electric ⚡️
How we are turning groundbreaking bioelectronics research into the future of advanced wound care. Our story began in Germany 🇩🇪 at the University of Freiburg, where we combined expertise in materials science, electrostimulation, electrochemistry, and biology to lay the foundations of our technology.→ Our Inventors & Co-Founders José Leal and Maria Asplund saw the possibilities […]
Chalmers Ventures Invests in Bioelectrix
Chalmers Ventures invests in Bioelectrix – groundbreaking technology to treat hard-to-heal wounds Bioelectrix is a new portfolio company at Chalmers Ventures. The company is taking on a global health problem—hard-to-heal wounds—by developing a solution that, using electrical stimulation and advanced, cost-effective materials, can steer skin cells back into the healing process. “This is a silent […]